Nike dips as BofA downgrades stock on longer-than-expected turnaround
Nike (NKE) shares fell over 2% premarket after BofA downgraded the stock to Underperform, lowering its price target to $30 from $47. The bank expects sales recovery to be delayed until fiscal 2028, with negative sales growth through fiscal 2027. BofA cut EPS estimates and lowered its income rating, citing weak North America wholesale performance and China market challenges.
How this was made
The 30-second read
Why it matters
The downgrade reflects a significant shift in earnings outlook, increasing downside risk for traders.
Market read
Nike's stock reacts sharply to the downgrade, highlighting immediate trading opportunity.
What to watch
Potential upside from lower tariff rates and cost‑cutting initiatives not fully priced yet.
Background
Nike's sales recovery timeline has been pushed to fiscal 2028, with negative growth expected through 2027.
Ticker impact
BofA downgraded Nike to Underperform and cut the price target to $30, causing a >2% pre‑market dip.
Further downside risk in the near term as investors reassess valuation.
Analyst cut EPS estimates 11‑12% and lowered target by 36%, a material shift that typically drives sell‑offs.
Market effects
Footwear and apparel sector may see broader pressure as peers' valuations are re‑priced.
U.S. consumer discretionary stocks could face short‑term weakness.
Limited to markets with exposure to Nike; no immediate global macro effect.
Counterpoint
If Nike can accelerate margin expansion and resolve inventory issues, the stock may be oversold.
Key entities
- AnalystBank of America
Downgraded Nike and revised price target.



